FATE — FATE THERAPEUTICS INC

Ownership history in Point72 (DIFC) Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in FATE THERAPEUTICS INC (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 10,465 -21,217 -67.0% 0.00% $12K $1.12
2024 Q4 INITIATED 31,682 — — 0.00% $52K $1.65
% of Fund (quarterly)    FATE price (monthly, adj. close)

Other funds also holding FATE

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 0.93% JOHNSON & JOHNSON 3Y 0.6% Bruce & Co., Inc. 3Y 7Y 0.22% Knott David M Jr 3Y 0.17% Monaco Asset Management SAM 3Y 0.14% DAFNA Capital Management LLC 3Y 7Y 0.13% Privium Fund Management B.V. 3Y 0.07% Vestal Point Capital, LP 0.06% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.06% Parametrica Management Ltd 3Y 7Y 0.03%
← Back to Point72 (DIFC) Ltd Holdings